234 related articles for article (PubMed ID: 1901563)
21. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
Dandona P; Jeremy JY
Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
[TBL] [Abstract][Full Text] [Related]
24. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
Arai Y; Tanaka K; Ushijima H; Tomisato W; Tsutsumi S; Aburaya M; Hoshino T; Yokomizo K; Suzuki K; Katsu T; Tsuchiya T; Mizushima T
Dig Dis Sci; 2005 Sep; 50(9):1641-6. PubMed ID: 16133963
[TBL] [Abstract][Full Text] [Related]
25. The pro-drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non-steroidal anti-inflammatory drugs.
Davies GR; Rampton DS
Aliment Pharmacol Ther; 1991 Dec; 5(6):593-8. PubMed ID: 1782303
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers.
Troost FJ; Saris WH; Brummer RJ
Eur J Clin Nutr; 2003 Dec; 57(12):1579-85. PubMed ID: 14647223
[TBL] [Abstract][Full Text] [Related]
27. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
[TBL] [Abstract][Full Text] [Related]
28. Do non-steroidal anti-inflammatory drugs increase colonic permeability?
Jenkins AP; Trew DR; Crump BJ; Nukajam WS; Foley JA; Menzies IS; Creamer B
Gut; 1991 Jan; 32(1):66-9. PubMed ID: 1899408
[TBL] [Abstract][Full Text] [Related]
29. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
[TBL] [Abstract][Full Text] [Related]
30. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
Melarange R; Spangler R; Hoult JR
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.
Reuter BK; Davies NM; Wallace JL
Gastroenterology; 1997 Jan; 112(1):109-17. PubMed ID: 8978349
[TBL] [Abstract][Full Text] [Related]
32. The effect of ingested lactulose on absorption of L-rhamnose, D-xylose, and 3-O-methyl-D-glucose in subjects with ileostomies.
Jenkins AP; Menzies IS; Nukajam WS; Creamer B
Scand J Gastroenterol; 1994 Sep; 29(9):820-5. PubMed ID: 7824862
[TBL] [Abstract][Full Text] [Related]
33. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability.
Davies GR; Wilkie ME; Rampton DS
Dig Dis Sci; 1993 Mar; 38(3):417-25. PubMed ID: 8444070
[TBL] [Abstract][Full Text] [Related]
34. The unique pharmacologic profile of nabumetone.
Blower PR
J Rheumatol Suppl; 1992 Nov; 36():13-9. PubMed ID: 1474529
[TBL] [Abstract][Full Text] [Related]
35. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios.
Oman H; Henriksson AE; Johansson SG; Blomquist L
Scand J Gastroenterol; 1996 Dec; 31(12):1182-8. PubMed ID: 8976010
[TBL] [Abstract][Full Text] [Related]
36. Experimental evidence of the benefit of misoprostol beyond the stomach in humans.
Bjarnason I
J Rheumatol Suppl; 1990 Feb; 20():38-41. PubMed ID: 2109075
[TBL] [Abstract][Full Text] [Related]
37. [Effects of NSAIDs and PGE1 analogue on the permeability of human small intestine].
Nagase K; Hiwatashi N; Ito K; Maekawa H; Noguchi M; Kinouchi Y; Toyota T
Nihon Shokakibyo Gakkai Zasshi; 1997 Jul; 94(7):469-74. PubMed ID: 9277110
[TBL] [Abstract][Full Text] [Related]
38. 2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum.
Somasundaram S; Simpson R; Rafi S; Shergill JK; Bjarnason I; Wrigglesworth J
BMC Gastroenterol; 2002 Apr; 2():8. PubMed ID: 11960558
[TBL] [Abstract][Full Text] [Related]
39. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability.
Ohri SK; Bjarnason I; Pathi V; Somasundaram S; Bowles CT; Keogh BE; Khaghani A; Menzies I; Yacoub MH; Taylor KM
Ann Thorac Surg; 1993 May; 55(5):1080-6. PubMed ID: 8494414
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers.
Davies NM; Jamali F
Hum Exp Toxicol; 1997 Jul; 16(7):345-9. PubMed ID: 9257157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
